Riverhead Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $144K | Buy |
2,400
+100
| +4% | +$6K | 0.01% | 1240 |
|
|
2019
Q2 | $194K | Hold |
2,300
| – | – | 0.01% | 1161 |
|
|
2019
Q1 | $220K | Hold |
2,300
| – | – | 0.01% | 1075 |
|
|
2018
Q4 | $163K | Buy |
2,300
+100
| +5% | +$7.09K | 0.01% | 1156 |
|
|
2018
Q3 | $188K | Buy |
2,200
+600
| +38% | +$51.3K | 0.01% | 1222 |
|
|
2018
Q2 | $185K | Hold |
1,600
| – | – | 0.01% | 1128 |
|
|
2018
Q1 | $129K | Buy |
+1,600
| New | +$129K | 0.01% | 1255 |
|
|
2017
Q1 | – | Sell |
-500
| Closed | -$17K | – | 1525 |
|
|
2016
Q4 | $17K | Hold |
500
| – | – | ﹤0.01% | 1435 |
|
|
2016
Q3 | $13K | Sell |
500
-5,792
| -92% | -$151K | ﹤0.01% | 1416 |
|
|
2016
Q2 | $324K | Buy |
6,292
+5,900
| +1,505% | +$304K | 0.01% | 712 |
|
|
2016
Q1 | $12K | Buy |
+392
| New | +$12K | ﹤0.01% | 1416 |
|